|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Term loans, fair value option (Amortized cost: $815,305 and $890,996) | |||||||||
| Fixed maturities, fair value option (Amortized cost: $546,878 and $477,548) | |||||||||
| Short-term investments, fair value option (Cost: $477,084 and $412,762) | |||||||||
| Equity securities, fair value option | |||||||||
| Other investments, fair value option | |||||||||
| Investments, fair value option | |||||||||
| Fixed maturities, available for sale (Amortized cost: $616,054 and $638,075) | |||||||||
| Equity securities, fair value through net income | |||||||||
| Total investments | |||||||||
| Cash and cash equivalents | |||||||||
| Accrued investment income | |||||||||
| Premiums receivable | |||||||||
| Reinsurance recoverable on unpaid and paid losses and loss adjustment expenses | |||||||||
| Prepaid reinsurance premiums | |||||||||
| Deferred acquisition costs, net | |||||||||
| Receivable for securities sold | |||||||||
| Intangible assets | |||||||||
| Funds held by reinsurers | |||||||||
| Other assets | |||||||||
| Total assets | |||||||||
| Liabilities | |||||||||
| Reserve for losses and loss adjustment expenses | |||||||||
| Unearned premiums | |||||||||
| Losses payable | |||||||||
| Reinsurance balances payable | |||||||||
| Payable for securities purchased | |||||||||
| Payable for securities sold short | |||||||||
| Revolving credit agreement borrowings | |||||||||
| Senior notes | |||||||||
| Amounts due to affiliates | |||||||||
| Investment management and performance fees payable | |||||||||
| Other liabilities | |||||||||
| Total liabilities | |||||||||
| Contingently redeemable preference shares | |||||||||
| Shareholders’ equity | |||||||||
| Common shares ($0.01 par; shares authorized: 120 million; shares issued and outstanding: 22,692,300 and 22,682,875) | |||||||||
| Common shares ($0.01 par; shares authorized: 120 million; shares issued: 22,813,915 and 22,804,128) | |||||||||
| Additional paid-in capital | |||||||||
| Retained earnings (deficit) | |||||||||
| Accumulated other comprehensive income (loss) | |||||||||
| Common shares held in treasury, at cost (shares: 2,917,149 and 2,917,149) | |||||||||
| Total shareholders’ equity | |||||||||
| Total liabilities, contingently redeemable preference shares and shareholders’ equity |
Loading...
